Pediatric Ideal reports have not been executed on the connection of age towards the effects of triazolam inside the pediatric populace. Security and efficacy have not been founded. Geriatric Suitable studies carried out up to now have not demonstrated geriatric-unique problems that may limit the usefulness of triazolam while in the aged.Bromazolam,